Trial intelligence / Profile preview

Vitamin D3 Effects on Immune Function in Pediatric SLE

NCT01709474Phase 2Terminated

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Jun 2013
Primary completion
Jul 2014
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of vitamin d in systemic lupus erythematosus (SLE), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2013; status: terminated.

02

Drugs

vitamin d
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on NCT01709474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01709474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call